Business Description
Champions Oncology Inc
NAICS : 325414
SIC : 2836
ISIN : US15870P3073
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | -0.01 | |||||
Debt-to-Equity | -21.41 | |||||
Debt-to-EBITDA | -6.09 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.05 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.5 | |||||
3-Year FCF Growth Rate | -14.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.18 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.68 | |||||
9-Day RSI | 30.9 | |||||
14-Day RSI | 38.89 | |||||
6-1 Month Momentum % | -10.92 | |||||
12-1 Month Momentum % | -30.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.69 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.15 | |||||
Days Sales Outstanding | 34.97 | |||||
Days Payable | 66.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 2.1 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.27 | |||||
Operating Margin % | -5.88 | |||||
Net Margin % | -6.58 | |||||
FCF Margin % | -3.85 | |||||
ROA % | -12.48 | |||||
ROIC % | -11.2 | |||||
3-Year ROIIC % | -178.11 | |||||
ROC (Joel Greenblatt) % | -23.56 | |||||
ROCE % | -47.42 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 33.33 | |||||
PS Ratio | 1.06 | |||||
EV-to-EBIT | -20.49 | |||||
EV-to-EBITDA | -53.33 | |||||
EV-to-Revenue | 1.21 | |||||
EV-to-Forward-Revenue | 1.26 | |||||
EV-to-FCF | -29.32 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Earnings Yield (Greenblatt) % | -4.88 | |||||
FCF Yield % | -3.45 |